Strategic Financial Concepts’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,836
Closed -$263 332
2024
Q2
$263 Buy
+14,836
New +$263 ﹤0.01% 695